T. Rowe Price Associates
CASI

T. Rowe Price Associates’s CASI Pharmaceuticals CASI Stock Holding History

T. Rowe Price Associates’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,750
Closed -$104K – 2988
2021
Q3 		$104K Sell
8,750
-1,770
-17% -$23.9K ﹤0.01% 2837
2021
Q2 		$163K Sell
10,520
-5,009
-32% -$84.3K ﹤0.01% 2768
2021
Q1 		$373K Buy
15,529
+4,237
+38% +$119K ﹤0.01% 2491
2020
Q4 		$333K Buy
11,292
+3,944
+54% +$85.7K ﹤0.01% 2390
2020
Q3 		$112K Hold
7,348
– – ﹤0.01% 2507
2020
Q2 		$184K Buy
7,348
+50
+0.7% +$1.09K ﹤0.01% 2366
2020
Q1 		$149K Hold
7,298
– – ﹤0.01% 2365
2019
Q4 		$225K Buy
7,298
+200
+3% +$6.49K ﹤0.01% 2385
2019
Q3 		$237K Buy
7,098
+31
+0.4% +$995 ﹤0.01% 2359
2019
Q2 		$226K Buy
7,067
+10
+0.1% +$319 ﹤0.01% 2383
2019
Q1 		$203K Buy
7,057
+10
+0.1% +$348 ﹤0.01% 2399
2018
Q4 		$283K Buy
7,047
+2,046
+41% +$77.5K ﹤0.01% 2310
2018
Q3 		$234K Buy
5,001
+28
+0.6% +$1.95K ﹤0.01% 2423
2018
Q2 		$409K Buy
4,973
+33
+0.7% +$2.23K ﹤0.01% 2234
2018
Q1 		$206K Sell
4,940
-100
-2% -$3.73K ﹤0.01% 2408
2017
Q4 		$164K Buy
+5,040
New +$137K ﹤0.01% 2448

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates's CASI Position: Q4 2021 in Review

T. Rowe Price Associates sold out of CASI Pharmaceuticals (CASI) in Q4 2021, closing a stake of 8,750 shares — an estimated $104K sold.

T. Rowe Price Associates first reported a position in CASI in Q4 2017 and held it in 16 quarters. The position peaked at $409K in Q2 2018. 51 funds tracked by Wall St. Rank hold CASI as of Q4 2021.

  • T. Rowe Price Associates reported no remaining CASI Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 8,750 CASI Pharmaceuticals shares in Q4 2021, an estimated $104K.
  • T. Rowe Price Associates first reported a position in CASI Pharmaceuticals in Q4 2017 and held it in 16 quarters.
  • T. Rowe Price Associates's CASI Pharmaceuticals position peaked at $409K in Q2 2018.
  • 51 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.